Fundamental dimension Equity attribute | APOLeader $112.83▼-1.74% Cap $66.63BP/E 24.4x QuantScore67/100 | ARESPeer $122.08▼-1.31% Cap $40.09BP/E 53.3x QuantScore48/100 | BXPeer $117.97▼-0.66% Cap $135.8BP/E 26.0x QuantScore55/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
55/100 |
70/100 |
63/100 |
Valuation Multiples, PEG & DCF upside | 94/100 | 32/100 | 53/100 |
Health Piotroski, Altman Z, leverage & liquidity | 68/100 | 14/100 | 47/100 |
Growth Revenue / earnings growth & margins | 52/100 | 64/100 | 57/100 |
Sentiment Analyst ratings, targets & revisions | 66/100 | 63/100 | 56/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 24.4x | 53.3x | 26.0x |
Forward P/E (next FY) | 13.0x | 21.2x | 20.0x |
EV / EBITDA (TTM) | 5.7x | 21.4x | 17.0x |
Price / Sales | 1.9x | 6.3x | 8.3x |
Price / Free Cash Flow | 8.3x | 47.9x | 47.8x |
PEG ratio | -1.71 | 1.86 | 0.88 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 6 / 9 | 6 / 9 |
Altman Z-Score | 0.28 (Distress) | 1.53 (Distress) | 3.78 (Safe) |
Total debt / equity | 0.65 | 3.75 | 1.61 |
Quick ratio | 3.2x | 0.8x | 1.2x |
Interest coverage | 20.0x | 2.0x | 15.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +22.7% | +66.6% | +21.6% |
Net income growth YoY | -21.1% | +13.7% | +8.7% |
Gross margin (TTM) | 84.5% | 62.7% | 89.7% |
Operating margin (FY) | 25.8% | 27.2% | 51.9% |
FCF margin (FY) | 23.3% | 49.4% | 12.6% |
5. Trailing price performancePrice change over period |
1M return | -6.5% | +1.6% | -0.4% |
3M return | -8.0% | -3.5% | -4.6% |
6M return | -9.2% | +5.9% | -2.9% |
Year to date | -22.1% | -24.5% | -23.0% |
1Y return | -9.7% | -18.3% | -23.4% |
3Y return | +34.3% | +16.9% | +28.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $525.49 +365.7% upside | $82.60 -32.3% premium | $42.84 -63.7% premium |
Wall Street consensus target | $136.00 +20.5% · range $127.00–$145.00 | $146.38 +19.9% · range $134.00–$168.00 | $143.45 +21.6% · range $118.00–$169.00 |
Consensus stance | 82% Buy18% Hold0% Sell | 77% Buy23% Hold0% Sell | 63% Buy33% Hold3% Sell |